can semaglutide cause vision loss Eye Damage Semaglutide linked to increased risk

A study published in Endocrinology found that diets enriched in monounsaturated fatty acids improved glycaemic tolerance specifically through increased GLP-1 secretion

Clinical trials that found a benefit typically measured results after 4 to 12 weeks of daily, uninterrupted use not days

Medullary Thyroid Carcinoma (MTC) and MEN2 MTC is rare, creating two realities: If a causal effect were large, it might be detectable in very large datasetsbut evidence has not established such a signal If a causal effect were small, enormous follow-up and careful subtype adjudication would be required Because the boxed warning is MTC/MEN2-specific, a conservative clinical approach is appropriate: Avoid GLP-1 RAs in patients with personal or family history of MTC Avoid GLP-1 RAs in MEN2 The Evidence by Subtype: For common thyroid cancers, the best evidence doesn't show causation

Interestingly, semaglutide therapy reduced cardiac and hepatic lipid content as well as lipid droplets in cardiac myocytes and hepatocytes